ĀÜĄņĀŅĀ×

Sharad S. Mansukani, M.D., CPE, CMCE, is the Chairman of the Board of Directors and was appointed to the Board of Directors in September 2019 following TPGā€™s acquisition of Convey. Dr. Mansukani has served as a senior advisor of TPG since 2005. From 2012 to 2015, Dr. Mansukani served as a strategic advisor to the Board of Directors of Cigna Corp. Prior to his work with Cigna Corp., Dr. Mansukani was appointed to Medicareā€™s Program Advisory and Oversight Committee by the Secretary of the Department of Health and Human Services from 2009 to 2012. Dr. Mansukani also served as a senior advisor to the Administrator of the Centers for Medicare and Medicaid Services (CMS) from 2003 to 2005, where he advised on design and implementation of the Medicare prescription drug benefit, Medicare Part B reform, and Medicare Advantage policy. Prior to his work with CMS, Dr. Mansukani was a Senior Vice President and Chief Medical Officer at Health Partners from 1999 to 2003. Dr. Mansukani currently serves on the Board of Directors of Agilon Health Solutions, and previously served as the Vice Chairman of the Board of Directors of Health Spring, Inc. from 2007 to 2012 and as Chairman of the Board of Directors of Envision Rx Options from 2013 to 2016. Dr. Mansukani also served on the boards of directors of Endo International PLC from 2017 to 2019, Kindred Healthcare Inc. from 2015 to 2018, Surgical Care Affiliates, Inc. from 2007 to 2017, IASIS Healthcare from 2005 to 2018, IMS Health Holdings, Inc. from 2009 to 2016, and Par Pharmaceutical Holdings, Inc. from 2012 to 2015 prior to Endo International PLCā€™s acquisition of Par Pharmaceutical Holdings, Inc. in 2015. Dr. Mansukani currently serves on the Board of Directors of the Childrenā€™s Hospital of Philadelphia.